Norgine invests £23m in expanding Welsh pharmaceuticals production

Leading European specialist pharmaceutical company Norgine is investing £23m expanding production of pharmaceuticals in Hengoed, South Wales.

(c) Christine Sandu/Unsplash

(c) Christine Sandu/Unsplash

Secretary of state for Wales Jo Stevens announced the expansion while visiting the firm on Thursday 5 March.

Stevens said: ‘We have a thriving life sciences sector in Wales, and this investment from Norgine is a vote of confidence in our Welsh workforce. I am delighted that UK Government funding is supporting the business to continue to grow and create new well-paid jobs.

‘Norgine is a brilliant example of an international business that is flourishing in Wales. With our new international programme we are going to build on successes like this to attract even more investment that will create opportunities all around Wales.'

The £23m investment will expand warehousing and production space to meet increasing demand, as well as creating 44 new jobs. It has been unlocked by the Life Sciences Innovative Manufacturing Fund (LSIMF), a cornerstone of the UK Government's commitment to strengthening the health sector and one of the six headline commitments within the Life Sciences Sector Plan.

Make or break for the Single Patient Record

Make or break for the Single Patient Record

26 October 2026

Professor Erika Denton, consultant radiologist and clinical advisor, Heidi, explains why data quality will make or break the Single Patient Record

Thousands more home-grown resident doctors secure NHS training posts

By Lee Peart 22 October 2026

Thousands more home-grown resident doctors have secured NHS training posts this year.

Next steps for National Care Service published in Wales

By Lee Peart 21 October 2026

A National Care Service Programme setting out how the Welsh Government will aim to create a more consistent and sustainable care system has been published.


Popular articles by Lee Peart